The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema

Journal of Diabetes and its Complications

Volumn 28, Issue 2, 2014, Pages 166-170

  Matsuda, Simone ^a,b   Tam, Tiffany ^a   Singh, Rishi P ^a   Kaiser, Peter K ^a   Petkovsek, Dan ^a   Carneiro, Glaucia ^b   Zanella, Maria Teresa ^b   Ehlers, Justis P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Avastin; Bevacizumab; Diabetic macular edema; Diabetic retinopathy; HbA1c; Metabolic parameters; VEGF; VEGF inhibitors

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CASE STUDY; CENTRAL MACULAR THICKNESS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINAL THICKNESS; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; VISUAL ACUITY;

AVASTIN; BEVACIZUMAB; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; HBA1C; METABOLIC PARAMETERS; VEGF; VEGF-INHIBITORS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896722099     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.11.009     Document Type: Article

References (26)

1. R. Benarous, M.B. Sasongko, and S. Qureshi et al. Differential association of serum lipids with diabetic retinopathy and diabetic macular edema Investigative Ophthalmology & Visual Science 52 10 2011, Sep 7464 7469
2. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 9735 2010 124 136
3. T.H. Chou, P.C. Wu, J.Z. Kuo, C.H. Lai, and C.N. Kuo Relationship of diabetic macular oedema with glycosylated haemoglobin Eye (London, England) 23 6 2009, Jun 1360 1363
4. J. Cunha-Vaz, Faria de Abreu JR, and A.J. Campos Early breakdown of the blood-retinal barrier in diabetes The British journal of ophthalmology 59 11 1975, Nov 649 656
5. D.V. Do, U. Schmidt-Erfurth, and V.H. Gonzalez et al. The DA VINCI Study: Phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema Ophthalmology 118 9 2011, Sep 1819 1826
6. Early photocoagulation for diabetic retinopathy ETDRS report number 9 Ophthalmology 98(5 Suppl) 1991, May Early Treatment Diabetic Retinopathy Study Research Group 766 785
7. H. Funatsu, H. Yamashita, H. Noma, T. Mimura, T. Yamashita, and S. Hori Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema American Journal of Ophthalmology 133 1 2002, Jan 70 77
8. F. Giorgino, A. Leonardini, and L. Laviola Cardiovascular disease and glycemic control in type 2 diabetes: Now that the dust is settling from large clinical trials Annals of the New York Academy of Sciences 1281 2013, Apr 36 50
9. W. Kerner The UK prospective diabetes study Lancet 352 9144 1998, Dec 12 1934
10. R. Klein, and B.E. Klein Are individuals with diabetes seeing better? A long-term epidemiological perspective Diabetes 59 8 2010, Aug 1853 1860
11. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruickshanks The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes Ophthalmology 105 10 1998, Oct 1801 1815
12. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, and D.L. DeMets The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema Ophthalmology 91(12 1984, Dec 1464 1474
13. P. Mitchell, F. Bandello, and U. Schmidt-Erfurth et al. The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 4 2011, Apr 615 625
14. Q.D. Nguyen, D.M. Brown, and D.M. Marcus et al. Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 4 2012, Apr 789 801
15. P.A. Ozer, N. Unlu, M.N. Demir, D.O. Hazirolan, M.A. Acar, and S. Duman Serum lipid profile in diabetic macular edema Journal of Diabetes and its Complications 23 4 2009, Jul-Aug 244 248
16. B.T. Ozturk, H. Kerimoglu, M. Adam, K. Gunduz, and S. Okudan Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema Journal of Diabetes and its Complications 25 5 2011, Sep-Oct 298 302
17. Photocoagulation for diabetic macular edema Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103(12) 1985, Dec Early Treatment Diabetic Retinopathy Study research group 1796 1806
18. Photocoagulation therapy for diabetic eye disease JAMA 254(21) 1985, Dec 6 Early Treatment Diabetic Retinopathy Study Research Group 3086
19. T. Qaum, Q. Xu, and A.M. Joussen et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes Investigative Ophthalmology & Visual Science 42 10 2001, Sep 2408 2413
20. R. Rajendram, S. Fraser-Bell, and A. Kaines et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3 Archives of Ophthalmology 130 8 2012 972 979
21. K.A. Solaiman, M.M. Diab, and M. Abo-Elenin Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema Retina 30 10 2010, Nov-Dec 1638 1645
22. M.J. Tolentino, J.W. Miller, and E.S. Gragoudas et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 11 1996, Nov 1820 1828
23. D.J. Wilson, D. Finkelstein, H.A. Quigley, and W.R. Green Macular grid photocoagulation. An experimental study on the primate retina Archives of Ophthalmology 106 1 1988, Jan 100 105
24. J.W. Yau, S.L. Rogers, and R. Kawasaki et al. Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 3 2012 556 564
25. X. Zhang, J.B. Saaddine, and C.F. Chou et al. Prevalence of diabetic retinopathy in the United States, 2005-2008 JAMA 304 6 2010 649 656
26. B. Zinman Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: Overcoming the barriers Diabetologia 40 Suppl 2 1997, Jul S88 S90